Ambulation Difficulty
Ambulation Difficulty
Explore linked clinical trials. Standard reference: MESH:M048042917 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing Interventions for Mobility Through Exercise (TIME) | Ambulation Difficulty, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Not applicable | 2026-10-05 | NCT05725564 | |
| Far Red Light to Improve Functioning in PAD | Ambulation Difficulty, Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2026-06-04 | NCT06165016 | |
| Physical Activity Level at Home in CMT1A Patients: Wearable Sensor Assessment | Ambulation Difficulty, Charcot-Marie-Tooth Disease, Type IA, Charcot-Marie-Tooth disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system malformation, hereditary disease, hereditary motor and sensory neuropathy, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy | Not yet recruiting | Not stated | 2026-05-22 | NCT07591779 | |
| ENhancing Exercise With LIGHT to Improve Functioning in PAD | Ambulation Difficulty, Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-04-15 | NCT06399900 | |
| Fisetin to Reduce Senescence and Mobility Impairment in PAD | Ambulation Difficulty, Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 2 | 2026-04-15 | NCT06399809 | |
| SMART Exercise for PAD | Ambulation Difficulty, Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 3 | 2026-04-15 | NCT06032065 | |
| A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy | Ambulation Difficulty, Brain Damage, Chronic, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, cerebral palsy, nervous system disorder, spastic diplegia | Recruiting | Not applicable | 2026-04-14 | NCT06454656 | |
| Randomized Clinical Trial to Improve Mobility After Hospitalization | Ambulation Difficulty, Mobility Limitation, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hypertensive disorder, metabolic disease, vascular disorder | Active, not recruiting | Not applicable | 2026-04-06 | NCT05736484 | |
| Biomarkers of Reaction To HIIT Exercise | Ambulation Difficulty, Mobility Limitation, Neurologic Manifestations, Paraparesis, Paraparesis, Spastic, Paresis, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-03-27 | NCT06059872 | |
| Exoskeleton and Spinal Cord Stimulation for SCI | Ambulation Difficulty, Mobility Limitation, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, injury, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury | Recruiting | Not applicable | 2026-01-14 | NCT03096197 | |
| Chronic Wounds and Blood Circulation Detection | Ambulation Difficulty, Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Mobility Limitation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-01-09 | NCT07330635 | |
| Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Lower Extremity in Chronic Stroke Patients | Ambulation Difficulty, Mobility Limitation, Neurologic Manifestations, Paresis, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemiplegia, nervous system disorder, palsy, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-11-25 | NCT07073235 | |
| Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MS | Ambulation Difficulty, CNS demyelinating autoimmune disease, Fatigue, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Not yet recruiting | Not applicable | 2025-09-10 | NCT06432686 | |
| To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors | Ambulation Difficulty, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-08-01 | NCT06247553 | |
| Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury | Ambulation Difficulty, Gait Disorders, Neurologic, Genital Diseases, Male Urogenital Diseases, Mobility Limitation, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, bone disorder, bone resorption disease, central nervous system disorder, endocrine system disorder, gonadal disorder, hypogonadism, injury, male reproductive system disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury | Recruiting | Phase 2 | 2025-05-06 | NCT04460872 | |
| Passive Stretching in Peripheral Arterial Disease Patients | Ambulation Difficulty, Arterial Occlusive Diseases, Inflammation, Mobility Limitation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 2 | 2025-04-02 | NCT06420752 | |
| Neuromusculoskeletal Modeling of Muscle Spasticity | Ambulation Difficulty, Brain Damage, Chronic, Mobility Limitation, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, cerebral palsy, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder | Enrolling by invitation | Not stated | 2022-07-07 | NCT05447299 |